Advertisement

Komplikationen bei Zeckenstichen: Ehrlichiose und Borreliose

  • Robert R. Müllegger
  • Andrea Rieger
  • Wolfgang Weger
Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 18)

Zusammenfassung

Zecken können weltweit zahlreiche Krankheitserreger auf den Menschen übertragen (Tabelle 1.) In Mitteleuropa kommt insbesondere dem Holzbock (Ixodes ricinus) Bedeutung als Vektor zu. Er überträgt vor allem die Spirochäte Borrelia burgdorferi sensu lato (Bb), den Auslöser der Lyme-Borreliose (LB), verschiedene Anaplasma- und Ehrlichien-Spezies (Auslöser der Ehrlichiose) sowie bestimmte Flaviviren als Auslöser der Frühsommermeningoenzephalitis (FSME). Diese drei Infektionskrankheiten unterscheiden sich deutlich hinsichtlich klinischem Bild, Häufigkeit, Schweregrad, Verlauf sowie Möglichkeiten der Behandlung und Prophylaxe. Die LB ist die häufigste zeckenübertragene Krankheit. In den USA werden jährlich mehr als 17.000 Fälle gemeldet, die Erkrankungszahlen haben über die Jahre laufend zugenommen. Die höchste Inzidenz wird von Connecticut berichtet (110/100.000 Einwohner und Jahr). In Europa kann von einer durchschnittlichen Inzidenz von 300/100.000 Einwohnern und Jahr ausgegangen werden [23].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Munoz J, Dumler JS (1996) Human granulocytic ehrlichiosis (HGE). A case series from a single medical center in New York State. Ann Intern Med 125: 904–908PubMedCrossRefGoogle Scholar
  2. 2.
    Aguero-Rosenfeld ME, Kalantarpour F, Baluch M, Horowitz HW, McKenna DF, Raffalli JT, Hsieh TC, Wu J, Dumler JS, Wormser GP (2000) Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol 38: 635–638PubMedCentralPubMedGoogle Scholar
  3. 3.
    Anonymous (1995) Lyme disease—United States, 1994. Morb Mortal Wkly Rep 44: 459–462Google Scholar
  4. 4.
    Åsbrink E, Hovmark A (1985) Successful cultivation of spi-rochetes from skin lesions of patients with erythema chro- nicum migrans Afzelius and acrodermatitis chronica atro-phicans. Acta Pathol Microbiol Immunol Scand B 93: 161–163PubMedGoogle Scholar
  5. 5.
    Åsbrink E, Olsson I (1985) Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. Acta Dermato Venereol (Stockh) 65:43–52Google Scholar
  6. 6.
    Åsbrink E, Hovmark A, Hederstedt B (1985) Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluores-cence and enzyme-linked immunosorbent assays. Acta Dermato Venereol (Stockh) 65: 509–514Google Scholar
  7. 7.
    Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH (1994) Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? J Am Med Ass 272: 212–218CrossRefGoogle Scholar
  8. 8.
    Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS (1996) Clinical and laboratory char-acteristics of human granulocytic ehrlichiosis. J Am Med Ass 275:199–205CrossRefGoogle Scholar
  9. 9.
    Dumler JS (2001) Molecular diagnosis of Lyme disease. Re-view and metaanalysis. Mol Diagn 6:1 -11PubMedCrossRefGoogle Scholar
  10. 10.
    Dumler JS, Barbet AF, Bekker CPJ, Dasch GA, Palmer GH, Ray SC, Rikihisa Y, Rurangirwa FR (2001) Reorganization of genera in the families Rickettsiaceae and Anaplasmata-ceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia, and Ehrlichia with Neorickettsia, description of six new species combinations and designation of Ehrlichia equi and ’HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Bacteriol 51: 2145–2165CrossRefGoogle Scholar
  11. 11.
    Edelman DC, Dumler JS (1996) Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagnosis 1:41–49CrossRefGoogle Scholar
  12. 12.
    Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Kurtti TJ, Munderloh UG (1996) Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 334: 209–215PubMedCrossRefGoogle Scholar
  13. 13.
    Hansen K (1993) Laboratory diagnostic methods in Lyme borreliosis. Clin Dermatol 11:407 - 414PubMedCrossRefGoogle Scholar
  14. 14.
    Krause P, McKay K, Thompson CA, Sikand VK, Lentz R, Lepore T, Closter L, Christianson D, Telford SR, Persing D, Radolf JD, Spielman A (2002) Disease-specific diagnosis of coinfecting tick-borne zoonoses; Babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 34: 1184–1191PubMedCrossRefGoogle Scholar
  15. 15.
    Lebech AM (2002) Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxo-nomic classification. APMIS 105 [suppl]: S1 -40Google Scholar
  16. 16.
    Maraspin V, Cimperman J, Lotric-Furlan S, Pleterski-Rig-ler D, Strle F (1996) Treatment of erythema migrans in pregnancy. Clin Infect Dis 22: 788 - 793PubMedCrossRefGoogle Scholar
  17. 17.
    Müllegger RR, McHugh G, Ruthazer R, Binder B, Kerl H, Steere AC (2000) Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol 115:1115–1123PubMedCrossRefGoogle Scholar
  18. 18.
    Müllegger RR, Glatz M, Kerl H (2002) Serologic follow-up of patients with erythema migrans after antibiotic therapy. J Invest Dermatol 119: 316Google Scholar
  19. 19.
    Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Aguero-Rosenfeld ME, Dennis DT, Wormser GP (2001) Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 345: 79–84PubMedCrossRefGoogle Scholar
  20. 20.
    Nowakowski J, Nadelman RB, Forseter G, McKenna D, Wormser GP (1995) Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol 32: 223 - 227PubMedCrossRefGoogle Scholar
  21. 21.
    Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, Wormser GP, Schriefer ME, Luft BJ (1999) Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 67: 3518 - 3524PubMedCentralPubMedGoogle Scholar
  22. 22.
    Stanek G (1991) Laboratory diagnosis and seroprevalence of Lyme borreliosis. Infection 19: 263 - 267PubMedCrossRefGoogle Scholar
  23. 23.
    Stanek G (1995) Lyme borreliosis. Wien Med Wochenschr 145 (7-8): 155–161PubMedGoogle Scholar
  24. 24.
    Stanek G, Kahl 0 (1999) Chemoprophylaxis for Lyme borreliosis? Zentralbl Bakteriol 289: 655–665PubMedCrossRefGoogle Scholar
  25. 25.
    Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, Guy E, Gray J (1996) European Union concerted action on risk assessment in Lyme borreliosis. Clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108: 741–747PubMedGoogle Scholar
  26. 26.
    Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE (1983) The early clinical manifestations of Lyme disease. Ann Intern Med 99: 76–82PubMedCrossRefGoogle Scholar
  27. 27.
    Weber K, Neubert U, Büchner SA (1993) Erythema mi-grans and early signs and symptoms. In: Weber K, Burgdorfer W (eds) Aspects of Lyme borreliosis. Springer, Berlin Heidelberg New York, pp 105 -121CrossRefGoogle Scholar
  28. 28.
    Weger W, Müllegger RR (2002) Histopathology and immu-nohistochemistry of dermatoborrelioses. Acta Dermato-ven APA 10: 135–142Google Scholar
  29. 29.
    Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, Rush TJ, Rahn DW, Coyle PK, Persing DH, Fish D, Luft BJ (2000) Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31 [suppl 1]: S1 -14CrossRefGoogle Scholar
  30. 30.
    Zöchling N, Müllegger RR, Schlüpen EM, Stumpenhausen G, Soyer HP, Wienecke R, Hödl S, Volkenandt M, Kerl H (1995) Molecular subtyping of Borrelia burgdorferi (Bb) in lesional skin from Styrian (Austrian) patients with various manifestations of dermatoborreliosis (DB). J Invest Der-matol 104: 687Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Robert R. Müllegger
  • Andrea Rieger
  • Wolfgang Weger

There are no affiliations available

Personalised recommendations